Zobrazeno 1 - 8
of 8
pro vyhledávání: '"M B Bansal"'
Ciprofloxacin monotherapy for acute pelvic infections: a comparison with clindamycin plus gentamicin
Publikováno v:
Obstetrics and gynecology. 78(4)
This prospective, randomized controlled study compared the efficacy and safety of ciprofloxacin alone versus a conventional two-drug regimen, clindamycin with gentamicin. The study group included 71 patients hospitalized for pelvic infections such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46221ac54066111c233eaeb149d3b4aa
https://pubmed.ncbi.nlm.nih.gov/1553193
https://pubmed.ncbi.nlm.nih.gov/1553193
Publikováno v:
The Journal of the Association of Physicians of India. 39(10)
Enoxacin, a new 6-fluoroquinolone known to be active in vitro against most common pulmonary pathogens, was evaluated in comparison with ceftazidime, a third generation cephalosporin proven to be effective in the treatment of gram negative pneumonias.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::cc84fa73035d08cdb20f8ef50ef3cea6
https://pubmed.ncbi.nlm.nih.gov/1816197
https://pubmed.ncbi.nlm.nih.gov/1816197
Publikováno v:
Microbios. 55(222)
Bacteroides fragilis is generally believed to be stimulated by bile. Although B. fragilis is rarely found in the human duodenum, it is relatively frequent in gall bladder infections. To investigate this paradox, the growth of B. fragilis in the human
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::3ce8a7759d644b75a1cbc82bbfc8bba9
https://pubmed.ncbi.nlm.nih.gov/3205170
https://pubmed.ncbi.nlm.nih.gov/3205170
Publikováno v:
Chemotherapy. 31(3)
The effect of clavulanic acid on the in vitro activity of beta-lactam antibiotics against Bacteroides fragilis (154 strains) was tested. The MIC90 on 154 strains of B. fragilis tested was greater than 64 micrograms/ml for penicillin and cephalothin,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b4a75965bb90d7b962da653515e2c6ff
https://pubmed.ncbi.nlm.nih.gov/3996086
https://pubmed.ncbi.nlm.nih.gov/3996086
In vitro activity of pipecolic acid amide of clindamycin (U-57930E) against 265 isolates of anaerobic bacteria, including 66 strains of Bacteroides fragilis, was compared with those of clindamycin, chloramphenicol, and cefoxitin. At therapeutically a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63a58db4f2586380b9dbdb3fa1fd1f9b
https://europepmc.org/articles/PMC183741/
https://europepmc.org/articles/PMC183741/
Autor:
H Thadepalli, M B Bansal
Carbenicillin, piperacillin, and mezlocillin, when combined with cefoxitin, exhibited synergism against 20, 13, and 10 isolates of Bacteroides fragilis, respectively, and no antagonism was observed in 19 of 20 strains. These results suggest that if b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9786514a4182d7bef5f8f05f56be68a
https://europepmc.org/articles/PMC184636/
https://europepmc.org/articles/PMC184636/
Publikováno v:
Obstetrics and gynecology. 66(3)
Cefmenoxime, a new third-generation cephalosporin, was used as a single drug in the therapy for female genital tract infections. Therapeutic response was considered satisfactory in 21 of 22 cases of pelvic inflammatory disease, six of nine tuboovaria
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2e44ed1a7a170b73e98ae42ad7d8922f
https://pubmed.ncbi.nlm.nih.gov/3860790
https://pubmed.ncbi.nlm.nih.gov/3860790
Autor:
H Thadepalli, M B Bansal
Publikováno v:
Antimicrobial agents and chemotherapy. 31(4)
We determined the MICs of difloxacin (A-56619) and A-56620 against anaerobic bacteria and assessed the effects of alterations in pH, size of inoculum, addition of human serum, and repeated exposure to subinhibitory levels of antibiotics. We tested fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f08c9f426e471c815b4ca982fbdc3cf4
https://pubmed.ncbi.nlm.nih.gov/3606066
https://pubmed.ncbi.nlm.nih.gov/3606066